New method for colorectal cancer diagnosis based on SSCP analysis of DNA from exfoliated colonocytes in naturally evacuated feces

Anticancer Research

Volumn 28, Issue 1 A, 2008, Pages 145-150

  Onouchi, Shigeki ^a   Matsushita, Hisayuki ^b   Moriya, Yoshihiro ^b   Akasu, Takayuki ^b   Fujita, Shin ^b   Yamamoto, Seiichiro ^b   Hasegawa, Hirotoshi ^c   Kitagawa, Yuko ^c   Matsumura, Yasuhiro ^a  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Colorectal cancer; Exfoliated colonocytes; Fecal DNA; Mass screening; SSCP analysis

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DNA EXTRACTION; DNA POLYMORPHISM; FECES ANALYSIS; FEMALE; GENE MUTATION; GENETIC IDENTIFICATION; HUMAN; HUMAN TISSUE; INTESTINE CELL; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; AGED; COLORECTAL NEOPLASMS; DNA, NEOPLASM; FECES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL;

EID: 40549084972     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. The Editorial Board of Cancer Statistics in Japan; Cancer Statistices IN Japan-2005. http://www.fpcr.or.jp.
2. Bosman FT: Prognostic value of pathological characteristics of colorectal cancer. Eur J Cancer 31: 1216-1221, 1995.
3. Towler B, Irwig L, Glasziou P, Kewenter J, Weller D and Silagy C: A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult. BMJ 317: 559-565, 1998.
4. Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, Ganiats T, Levin T, Woolf S, Johnson D, Kirk L, Litin S and Simmang C; Gastrointestinal Consortium Panel: colorectal cancer screening and surveillance: Clinical guidelines and rationale-Update based on new evidence. Gastroenterology 124: 544-560, 2003.
5. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, Snover DC and Schuman LM: The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 343: 1603-1607, 2000.
6. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM and Ederer F: Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 328: 1365-1371, 1993.
7. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW and James PD and Mangham CM: Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348: 1472-1477, 1996.
8. Kronborg O, Fenger C, Olsen J, Jorgensen OD and Sondergaard O: Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 348: 1467-1471, 1996.
9. Lieberman DA and Weiss DG: Veterans Affairs Cooperative Study Group 380: One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med 345: 555-560, 2001.
10. Sung JJY, Chan FKL, Leung WK, Wu JCY, Lau JYW, Chang J, TO KF, Lee YT, Luk YW, Kung NNS, Kwok SPY, Li MKW and Chung SCS: Screening for colorectal cancer in Chinese: comparison of fecal occult blood test, flexible sigmoidoscopy, and colonoscopy. Gastroenterology 124: 608-614, 2003.
11. Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA and Ross ME; Colorectal Cancer Study Group: Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 351: 2704-2714, 2004.
12. Sidransky D, Tokino T, Hamilton SR, Kinzler KW, Levin B, Frost P and Vogelstein B: Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 256: 102-105, 1992.
13. Hasegawa Y, Takeda S, Ichii S, Koizumi K, Maruyama M, Fujii A, Ohta H, Nakajima T, Okuda M, Baba S and Nakamura Y: Detection of K-ras mutations in DNAs isolated from feces of patients with colorectal tumors by mutant-allele- specific amplification (MASA). Oncogene 10: 1441-1445, 1995.
14. Smith-Ravin J, England J, Talbot IC and Bodmer W: Detection of c-Ki-ras mutations in faecal samples from sporadic colorectal cancer patients. Gut 36: 81-86, 1995.
15. Eguchi S, Kohara N, Komuta K and Kanematsu T: Mutations of the p53 gene in the stool of patients with resectable colorectal cancer. Cancer 77: 1707-1710, 1996.
16. Nollau P, Moser C, Weinland G and Wagener C: Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCR. Int J Cancer 66: 332-336, 1996.
17. Ratto C, Flamini G, Sofo L, Nucera P, Ippoliti M, Curigliano G, Ferretti G, Sgambato A, Merico M, Doglietto GB, Cittadini A and Crucitti F: Detection of oncogene mutation from neoplastic colonic cells exfoliated in feces. Dis Colon Rectum 39: 1238-1244, 1996.
18. Deuter R and Muller O: Detection of APC mutations in stool DNA of patients with colorectal cancer by HD-PCR. Hum Mutat 11: 84-89,1998.
19. Ahlquist DA, Skoletsky JE, Boynton KA, Harrington JJ, Mahoney DW, Pierceall WE, Thibodeau SN and Shuber AP: Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology 119: 1219-1227, 2000.
20. Dong SM, Traverso G, Johnson C, Geng L, Favis R, Boynton K, Hibi K, Goodman SN, D'Allessio M, Paty P, Hamilton SR, Sidransky D, Barany F, Levin B, Shuber A, Kinzler KW, Vogelstein B and Jen J: Detecting colorectal cancer in stool with the use of multiple genetic targets. J Natl Cancer Inst 93: 858-865, 2001.
21. Rengucci C, Maiolo P, Saragoni L, Zoli W, Amadori D and Calistri D: Multiple detection of genetic alterations in tumors and stool. Clin Cancer Res 7: 590-593, 2001.
22. Traverso G, Shuber A, Olsson L, Levin B, Johnson C, Hamilton SR, Boynton K, Kinzler KW and Vogelstein B: Detection of proximal colorectal cancers through analysis of faecal DNA. Lancet 359: 403-404, 2002.
23. Traverso G, Shuber A, Levin B, Johnson C, Olsson L, Schoetz DJ Jr, Hamilton SR, Boynton K, Kinzler KW and Vogelstein B: Detection of APC mutations in fecal DNA from patients with colorectal tumors. N Engl J Med 346: 311-320, 2002.
24. Boynton KA, Summerhayes IC, Ahlquist DA and Shuber AP: DNA integrity as a potential marker for stool-based detection of colorectal cancer. Clin Chem 49: 1058-1065, 2003.
25. Matsushita H, Matsumura Y, Moriya Y, Alasu T, Fujita S, Yamamoto S, Onouchi S, Saito N, Sugito M, Ito M, Kozo T, Minowa T, Nomura S, Tsunoda H and Kakizoe T: A New Method for Isolating Colonocytes From Naturally Evacuated Feces and Its Clinical Application to Colorectal Cancer Diagnosis. Gastroenterology 129: 1918-1927, 2005.
26. Orita M, Suzuki Y, Sekiya T and Hayashi K: Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction Genomics 5: 874-879, 1989.
27. Hayashi K: PCR-SSCP: A simple and sensitive method for detection of mutations in the genomic DNA. PCR Methods Appl 1: 34-38, 1991.
28. Winter MJ, Nagtegaal ID, van Krieken JH and Litvinov SV: The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathology. Am J Pathol 163: 2139-2148, 2003.
29. Balzar M, Prins FA, Bakker HAM, Fleuren GJ, Warnaar SO and Litvinov SV: The structural analysis of adhesions mediated by Ep-CAM. Exp Cell Res 246: 108-121, 1999.
30. Salem RR, Wolf BC, Sears HF, Lavin PT, Ravikumar TS, DeCoste D, D'Emilia JC, Herlyn M, Schlom J and Gottlieb LS: Expression of colorectal carcinoma-associated antigens in colonic polyps. J Surg Res 55: 249-255, 1993.
31. Yamao T, Matsumura Y, Shimada Y, Moriya Y, Sugihara K, Akasu T, Fujita S and Kakizoe T: Abnormal expression of CD44 variants in the exfoliated cells in the feces of patients with colorectal cancer. Gastroenterology 114: 1196-1205, 1998.
32. Matsumura Y and Tarin D: Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 340: 1053-1058, 1992.
33. Matsumura Y, Hanbury D, Smith J and Tarin D: Non-invasive detection of malignancy by identification of unusual CD44 gene activity in exfoliated cancer cells. BMJ 308: 619-624, 1994.